Objective: Utilizing a standardized dataset with specific definitions to prospectively collect international data to provide a benchmark for complications and outcomes associated with esophagectomy. Summary of Background Data: Outcome reporting in oncologic surgery has suffered from the lack of a standardized system for reporting operative results particularly complications. This is particularly the case for esophagectomy affecting the accuracy and relevance of international outcome assessments, clinical trial results, and quality improvement projects. Methods: The Esophageal Complications Consensus Group (ECCG) involving 24 high-volume esophageal surgical centers in 14 countries developed a standardized platform for recording complications and quality measures associated with esophagectomy. Using a secure online database (ESODA-TA.org), ECCG centers prospectively recorded data on all resections according to the ECCG platform from these centers over a 2-year period. Results: Between January 2015 and December 2016, 2704 resections were entered into the database. All demographic and follow-up data fields were 100% complete. The majority of operations were for cancer (95.6%) and typically located in the distal esophagus (56.2%). Some 1192 patients received neoadjuvant chemoradiation (46.1%) and 763 neoadjuvant chemotherapy (29.5%). Surgical approach involved open procedures in 52.1% and minimally invasive operations in 47.9%. Chest anastomoses were done most commonly (60.7%) and R0 resections were accomplished in 93.4% of patients. The overall incidence of complications was 59% with the most common individual complications being pneumonia (14.6%) and atrial dysrhythmia (14.5%). Anastomotic leak, conduit necrosis, chyle leaks, recurrent nerve injury occurred in 11.4%, 1.3%, 4.7%, and 4.2% of cases, respectively. Clavien-Dindo complications ! IIIb occurred in 17.2% of patients. Readmissions occurred in 11.2% of cases and 30-and 90-day mortality was 2.4% and 4.5%, respectively. Conclusion: Standardized methods provide contemporary international benchmarks for reporting outcomes after esophagectomy.
(Ann Surg 2019;269:291-298) E sophagectomy retains an important role in the management of many patients with locally advanced esophageal cancer, often in conjunction with neoadjuvant therapy.
Reviews of national datasets from North America confirm that esophagectomy 30-day mortality remains above 5%.
1 National audits and meta-analyses have demonstrated that in-hospital and 90-day mortality more accurately reflect actual mortality associated with esophagectomy with in-hospital mortality being approximately 7% to 8% and 90-day mortality as high as 13% when assessed from all centers performing any annual volume of esophageal resections. [2] [3] [4] The incidence of complications associated with esophagectomy has been previously reported between 17% and 74%. 5, 6 Irrespective of whether these outcomes originate from national audits or databases from single centers, all of these results have suffered from the absence of a standardized system for documenting and reporting operative outcomes including complications. Previous meta-analyses have documented considerable heterogeneity in the methodology of defining and reporting esophagectomy complications. 7 The absence of a standardized method of reporting perioperative outcomes means that there is no reliable method to compare reports from different institutions or assess the effect of quality improvement initiatives on mortality and perioperative complications. It has also resulted in the failure of the surgical community to generate a truly representative reflection of contemporary short-term outcomes associated with esophagectomy.
The Esophageal Complications Consensus Group (ECCG) was formed in 2011 and included 21 esophageal surgeons from high-volume centers representing 14 countries. Through a series of Delphi surveys and face-to-face meetings, the ECCG developed a standardized platform for reporting mortality, complications, and quality measures associated with esophagectomy that was published in 2015. 8 Having produced a system for reporting outcomes associated with esophagectomy, the ECCG agreed to test the system. The hypothesis was that a web-based dataset could be used to document outcomes according to the ECCG platform in international highvolume esophagectomy centers and that this would disclose less variation in complication rates than previously reported. The inclusion of all esophagectomies done over a 2-year period within the ECCG centers should provide a contemporary benchmark of morbidity and mortality associated with esophageal resection.
METHODS
A web-based dataset incorporating all of the data items and definitions published previously was developed to facilitate contemporary data collection. 8 In March 2015, the ECCG reached a consensus regarding additional demographic, surgical, and outcomes data fields that were considered critical to collect in addition to the complications platform, definitions, and quality measures. Nineteen original ECCG centers and 5 new high-volume esophagectomy units agreed to submit patients (Fig. 1) . A study protocol was distributed to the study centers. All centers signed the membership agreement (see Supplement 1, http://links.lww.com/SLA/B353) and agreed to fulfill all institutional and national ethics and IRB requirements in order to supply anonymized patient information to the database. All participating centers agreed to enroll all esophagectomies at their institutions during the study period.
After arriving at a consensus for determining the data fields, face-to-face ECCG meetings were held to review the specific issues involved in the implementation of a web-based international data collection project. Consensus-based data fields and definitions mandated a consistent and ''user-friendly'' platform to encourage participation while maintaining data integrity and completeness. To overcome variations in computer systems and capabilities between participating centers, a database was developed with secure access that offered a web browser based interface using existing computer systems without the requirement for additional local resource utilization or IT support other than internet connection involving both desktop and mobile devices. Validation algorithms were built into the database interface to ensure that only validated data was entered. The database and the web portal were hosted in a highperformance, dedicated private web server and the database interface was accessible only via authenticated and encrypted secure network connections (SSL Client and Server Certificate with Extended Validation-Issued by Symantec Corporation). Open-sourced database server package (Maria DB V10.1.21 by Maria DB FOUNDATION) with appropriate backup system arrangements in combination with Drupal content management software (distributed under the terms of the GNU General Public License) was used. This system provided data portability, analytics, modularity, and flexibility in content access management. Participating institutes' data-contributing members were authenticated individually by the ECCG to access the database's interface and members-only area of the ESODATA.org web portal. Authenticated contributors had instant access to their own institutional results on the ESODATA website that was available to them whenever they had secure internet web access. Contributors received regular email communications every 3 to 4 months updating them on patient accrual and intermediateterm results.
It was agreed that the study period should run between January 2015 and December 2016. Data entry began at the time each institution adopted the ECCG platform within their institutional datasets. It was agreed that the study population should yield at least 1200 resections with the goal being to record complications associated with both benign and malignant resections. No formalized system of audit was available for the study, although all centers signed and agreed to adhere to the Members Agreement (see Supplement 1, http://links.lww.com/SLA/B353). From September 2016, the International Society for Diseases of the Esophagus (ISDE) Executive acted as an external body to provide oversight of the ESODATA website and database.
STATISTICAL METHODS
The characteristics of the patient population are reported using frequency and percentage for categorical variables and 95% confidence limits for non-normally distributed continuous variables. The incidence of complications associated with each patient subgroup was also described using frequency and percentage with 95% confidence limits. Statistical analyses of the present study were performed using SPSS software (version 23.0; IBM Corp., Armonk, NY).
RESULTS
From January 2015 to December 2016, 2704 esophagectomies were enrolled in the ESODATA database website. All esophagectomies done at each institution during the study period from the time of the initiation of the ECCG complications platform were included. Data were 100% complete in all demographic and outcome data fields. Patient demographics and data regarding surgical technique are summarized in Table 1 . Over 99% of esophagectomies were elective and 95.6% of resections were for malignant disease with the most common tumor location being the distal esophagus (56.2%).
Within the study population of 2704, 2585 patients underwent esophagectomy for malignant disease. Among the patients undergoing resection for cancer, 1722 patients presented with cT3 disease (66.6%) and 1395 patients presented with findings of cNþ (53.9%) All data for both clinical and pathologic staging are shown in Supplement 2, http://links.lww.com/SLA/B353. Of these 2585 patients undergoing esophageal resections for cancer, 1192 patients (46.1%) received neoadjuvant chemoradiotherapy, 763 patients (29.5%) neoadjuvant chemotherapy, and 3.1% had esophagectomy as a salvage operation after definitive Chest anastomoses were most commonly utilized (60.7%) and reconstructions utilizing stomach were done in 94.9% of cases. Twofield lymphadenectomy was reported in 93% with 3-field procedures occurring in 7%. An R0 resection margin was achieved in 93.4% of operations.
The overall incidence of complications was 59.0%. In the 1595 patients who sustained complications, 905 (56.7%) experienced multiple complications (Table 2 ). Table 3 demonstrates the incidence of individual complications along with the variation (95% confidence limit) of the incidences of complication within the data contributing ECCG centers. The most common complications were pneumonia (14.6%) and atrial dysrhythmias (14.5%). The actual number of complications in each complication groups and variations in individual complication rates among the data contributing ECCG centers are summarized in Table 3 . Overall, the incidence of anastomotic leak was 11.4%, conduit necrosis 1.3%, chyle leak 4.7% with recurrent nerve injury in 4.2%. Specific outcomes according to ECCG definitions 8 are summarized in Table 4 . Complications graded by the Clavien-Dindo Classification are summarized in Table 5 with 17.2% of patients sustaining complications ! ClavienDindo IIIb.
Mortality was 2.4% at 30 days and 4.5% at 90 days (Table 6 ). Follow-up of 30-day mortality and readmissions is 100% complete. Ninety-day mortality was available in 99.6% of the study population, with 11 out of 2704 patients lost to follow-up between 30 and 90 days of post post-op. Readmissions were recorded if they occurred within 30 days of discharge. These occurred for any reason in 11.2% of patients (Table 6) . Of the 275 patients who required readmission related to their esophagectomy, 214 (77.6%) had experienced postoperative complications. Some 62 (22.4%) patients required readmission without experiencing inpatient complications.
DISCUSSION
Esophagectomy has historically been recognized as one of the most complex major oncologic operations. A meta-analysis of 122 publications including 17 randomized controlled clinical trials and 105 observational studies involving over 57,000 esophagectomies indicated that no complication appeared in all reports and more than 67% of studies contained no definitions. In addition, 115 reports utilized 10 different methods for reporting mortality. 7 This variability in reporting makes it impossible to make comparisons between national audits or clinical trials or to assess results in response to quality improvement initiatives between institutions.
Accuracy and consistency in reporting complications is critically important. Complications have been directly associated with every other critical outcome parameter associated with the surgical treatment of esophageal cancer. The incidence of complications has been directly linked to operative mortality, 7,9,10 cancer recurrence, 11, 12 cancer survival, 10,13 hospital length of stay, 10, [13] [14] [15] readmissions, [16] [17] [18] hospital costs, [19] [20] [21] hospital profit margin 21 as well as health-related quality of life. [22] [23] [24] Generating an accurate reflection of contemporary morbidity and mortality is particularly important, as the role of surgery in the treatment of a variety of stages of esophageal malignancy is undergoing continuous assessment.
The ECCG complications platform was not intended to represent every potential problem that may occur following esophagectomy, but developed as a standardized system for reporting the common and relevant aspects of morbidity and mortality associated with esophageal resection. The system utilizes internationally recognized definitions when appropriate, as well as definitions previously developed by the ECCG membership notably for anastomotic leak, conduit necrosis, chyle leak, and recurrent nerve injury. 8 These specific definitions were considered a critical component as a previous report documented no less than 56 different definitions for anastomotic leak in 97 publications reporting surgical adverse events. 25 The specific definitions enable comprehensive reporting of these important complications reflecting the severity and treatment requirements in all instances, not necessarily represented in either the Accordion 26 or the Clavien-Dindo 27 severity stratification systems that report only the most severe complication.
The overall incidence of complications was 59.0%. This incidence of complications is twice that reported in some comprehensive national audits of esophagectomy, 28 and other analyses have demonstrated that complication rates vary enormously between cohorts in different studies. 5, 6 When a standardized approach has been applied, as in the present study, this high incidence of complications showed remarkably little variation between the 24 contributing centers (Table 3 ). This suggests that 59% is more likely to be the true rate of complications after esophagectomy and that previous explanations for variations, reflecting different patient demographics, are no longer tenable.
In some instances, the incidence of individual complications was lower than that seen in previous reports, such as pneumonia with an overall incidence of 14.6%. This may be due to the fact that this report is based on very recent data and modern practice, potentially reflecting the use of standardized clinical pathways, ERAS protocols, and a decreased likelihood of failure to rescue 29, 30 in high-volume esophagectomy centers. The quality of the contributing centers is reflected in a 30-day mortality rate of 2.4%, 90-day mortality of 4.5% an R0 resection rate of 93.4%, and a readmission rate of 11.2%. These results can be compared with reports of national audits, but drawing conclusions will be difficult due to the lack of the focused and standardized system applied in the current study. For example, the STS database, although a very well-established dataset focuses on staging and procedure-specific outcome measures, does not currently contain the granularity necessary for providing a comprehensive report on shortterm complications.
The use of a secure online database was designed to improve accessibility while standardizing data input and providing instantaneous reporting of individual institutional data that could be assessed anywhere with internet access along with a format for center-specific internal audit. No center reported difficulties with data entry or access to the system during the course of the study. Ease of access and data entry were likely major contributors to data completeness.
The strengths of the present study include the use of a protocol and dataset specifically aimed to facilitate data collection related to patient demographics and complications associated with esophagectomy. The centers were all high-volume units with a history of institutional data collection and previous publications of esophagectomy outcomes. In addition, all individuals entering data were registered and authenticated. All demographic, outcome, and complications data entry fields were complete. Follow-up outcomes including 30-day mortality and readmissions data complete in 100% and 90-day mortality data were complete in 99.6% of patients. The dataset is large involving over 2700 patients accrued in a short time period and gathered internationally, making outcomes relevant to current practice at a global level.
Data entry was simplified using dropdown boxes utilizing modern web browser interface and data entry could take place anywhere that had internet access via HTTPS (Hyper Text Transfer Protocol Secure) network communication. The present study does have limitations. Other than the signed Members Agreement (Supplement 1, http://links.lww.com/SLA/ B353), there was no method in place for auditing individual institutional data. The study was not designed, and did not include data on patient quality of life or cancer survival.
These outcomes provide a contemporary benchmark for morbidity and mortality associated with esophagectomy. They reflect current international practice and probably represent the most reliable estimates of esophagectomy outcomes presently available. Secure online data collection has been demonstrated to be a very efficient methodology for carrying out this multi-institution international clinical trial. We predict that this methodology will be utilized regularly in national and international datasets moving forward.
The ECCG system, now overseen by the Research and Database Committee of the ISDE, should be considered for routine international application in audits and clinical trials as a means of standardizing esophagectomy outcomes. Information on the ESODATA dataset is available at the project web portal (https:// esodata.org). One of the most important members of the ECCG passed away in July 2017.
Professor Dr. Christophe Mariette, Head of the Department of Digestive and Oncologic Surgery, CHRU de Lille, France, was an internationally recognized surgeon and academic. He was a friend and counsellor throughout the ECCG project. He will be greatly missed and the Members of the ECCG respectfully dedicate this paper to his memory.
